MTNR1A Knockout HEK293 Cell Line
Cat.No.:
EDC07578
Species:
Human
Cell Name:
HEK293
Gene:
MTNR1A
Gene ID:
4543
Size:
1×10⁶cells
MTNR1A Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07578 |
|---|---|
| Product Name | MTNR1A Knockout Cell Line(HEK 293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | MTNR1A |
| NCBI Gene ID | |
| Gene Synonyms | MEL-1A-R|MT1 |
| Summary |
This gene encodes one of two high affinity forms of a receptor for melatonin, the primary hormone secreted by the pineal gland. This receptor is a G-protein coupled, 7-transmembrane receptor that is responsible for melatonin effects on mammalian circadian rhythm and reproductive alterations affected by day length. The receptor is an integral membrane protein that is readily detectable and localized to two specific regions of the brain. The hypothalamic suprachiasmatic nucleus appears to be involved in circadian rhythm while the hypophysial pars tuberalis may be responsible for the reproductive effects of melatonin. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying MTNR1A function, MTNR1A Knockout HEK293 Cell Line or MTNR1A overexpression HEK293 Cell Line?
The choice depends on whether you are studying MTNR1A (MT1, melatonin receptor type 1A)'s role as a Gi-coupled melatonin receptor or its functions in circadian rhythm regulation and sleep biology. The Knockout line is the standard tool for asking whether MT1 is required for melatonin-induced signaling — MT1 is a seven-transmembrane GPCR that, with MT2 (MTNR1B), mediates melatonin's circadian and sleep-promoting effects through Gi-coupled cAMP suppression and other downstream signaling. Overexpression is useful for studying MT1 in heterologous expression contexts.
For circadian rhythm and sleep research, the EDITGENE MTNR1A Knockout in HEK293 is a mechanistic platform — HEK293 supports systematic structure-function studies of MT1. MTNR1B (MT2) paralog expression analysis is essential given partial functional overlap. Rescue with wild-type or signaling-deficient MT1 is the standard specificity control. The knockout is a critical specificity tool for ramelteon (FDA-approved MT1/MT2 agonist for insomnia), agomelatine (depression/MT receptors), tasimelteon (non-24-hour sleep-wake disorder), and emerging melatonin receptor modulators.
What are the application scenarios for this model?
Primary applications:
• Melatonin-induced signaling: cAMP suppression following melatonin stimulation (Gi-coupled receptor signaling) to characterize MT1-dependent signaling.
• Ramelteon specificity: critical genetic control for ramelteon (Rozerem) — the FDA-approved MT1/MT2 agonist for chronic insomnia.
• Agomelatine and tasimelteon studies: assessment of these melatonin receptor modulators in MT1-null background.
• MTNR1A polymorphism studies: rescue with disease-associated MTNR1A polymorphisms for pharmacogenomic studies.
EDITGENE recommends this model for researchers investigating melatonin receptor biology, circadian rhythm pharmacology, and sleep disorder therapeutic development.
Is this MTNR1A Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. MT1 rescue experiments are well-established for GPCR pharmacology research:
• Construct design: use a codon-modified MTNR1A sequence with a small intracellular C-terminal tag (FLAG, HA). MT1 is a seven-transmembrane GPCR — preserve extracellular ligand-binding pocket.
• Signaling-deficient rescue: DRY motif mutations or specific intracellular loop mutations disrupt Gi-coupling.
• Surface localization validation: confirm plasma membrane localization by cell surface staining.
• Functional readout: rescue should restore melatonin-induced cAMP suppression (Gi signaling) and ramelteon responsiveness.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download